Sign in

Filings

Finds words inside filing documents. Searching Shuttle Pharmaceuticals Holdings, Inc.'s filings · 48 documents indexed.

7 documents · 25 matches

  1. SHPH Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2026-09-24

    Item 4. Controls and Procedures

    material weaknesses and control deficiencies. Such material weaknesses and control deficiencies will not be fully remediated until the Company has concluded
    3 matches in this document
  2. SHPH Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2026-05-15

    Item 4. Controls and Procedures

    material weaknesses and control deficiencies. Such material weaknesses and control deficiencies will not be fully remediated until the Company has concluded
    3 matches in this document
  3. SHPH Shuttle Pharmaceuticals Holdings, Inc. 10-K 2026-03-31

    Item 9A. Controls and Procedures

    material weaknesses and control deficiencies. Such material weaknesses and control deficiencies will not be fully remediated until the Company has concluded
    3 matches in this document
  4. SHPH Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2025-11-13

    Item 4. Controls and Procedures

    material weaknesses and control deficiencies. Such material weaknesses and control deficiencies will not be fully remediated until the Company has concluded
    3 matches in this document
  5. SHPH Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2025-08-13

    Item 4. Controls and Procedures

    material weaknesses and control deficiencies. Such material weaknesses and control deficiencies will not be fully remediated until the Company has concluded
    5 matches in this document
  6. SHPH Shuttle Pharmaceuticals Holdings, Inc. 10-Q 2025-05-08

    Item 4. Controls and Procedures

    material weaknesses and control deficiencies. Such material weaknesses and control deficiencies will not be fully remediated until the Company has concluded
    5 matches in this document
  7. SHPH Shuttle Pharmaceuticals Holdings, Inc. 8-K 2026-10-22

    Item 4.01. Changes in Registrant’s Certifying Accountant.

    material weaknesses with Forvis Mazars, and the Company has authorized Forvis Mazars to respond fully to the inquiries of the successor
    3 matches in this document

Page 1 of 1 · 7 documents